Can CBD Be Used In The Fight Against Infection?

The relationship in between infection and traditional antibiotics

Could CBD work in the fight versus resistant bacterial stress? The results from the University of Queensland in Australia suggest that it is possible. However before taking a look at the study in depth, it is useful to understand the development of the relationship in between germs and antibiotics.

Given that the advanced discovery of penicillin by Alexander Fleming in 1928, antibiotics have been a necessary tool in the fight versus germs and infections. And although we still utilize the same tested approaches today, germs have progressed. When exposed to antibiotics, certain germs, fungis and parasites are able to adapt and cancel the efficiency of the drug by developing resistance.

It’s worth mentioning that antimicrobial resistance was most likely to take place anyway, as the hereditary code for germs changes over time. Nevertheless, it is believed that the overuse of antibiotics is an essential factor that speeds up the advancement of resistant stress.

According to the World Health Organization, antimicrobial resistance “is a significantly serious threat to international public health that needs action in all sectors of federal government and in society.” This has actually led researchers to think outside package by attempting to recognize substances that could be beneficial in the fight versus harmful germs. One of these substances is cannabidiol (CBD), a cannabinoid discovered in Cannabis sativa.

Researchers are looking for brand-new methods to attack infections and resistant germs.

Dr. Mark Blaskovich, Principal Investigator and Program Coordinator for the Community for Open Antimicrobial Drug Discovery and Senior Research Officer at the Institute for Molecular Bioscience at the University of Queensland, concluded that CBD is effective versus Gram-positive germs. Strains of Gram-positive germs include Staphylococcus aureus (typical in skin infections) and Streptococcus pneumoniae (typical in bacterial pneumonia).

Dr. Blaskovich provided his findings at a yearly conference of the American Society for Microbiology. In vitro samples of both kinds of gram-positive germs were treated with synthetic CBD. The results led Dr. Blaskovich to the conclusion that CBD works at levels similar to those of prescription antibiotics vancomycin and daptomycin. He also discovered that CBD appeared to work against gram-positive stress of resistant germs, which many standard antibiotics are beginning to fail.

” In particular, the activity was selected versus the resistant stress of Staphylococcus aureus (MRSA, VISA, SARV), Streptococcus pneumoniae (MDR), and Enterococcus faecalis (ERV). Cannabidiol was bactericidal, had a low propensity to cause resistance and was active versus MRSA biofilms. “

The group also carried out another study utilizing topical CBD to treat a skin infection in mice. Again, although the results were positive, CBD did not appear to get rid of the infection, however simply to reduce the number of bacterial cells. CBD Cities has a fuller explanation.

Could CBD end up being an antibiotic?

While it is easy to hail this work as a considerable advancement in the anti-bacterial capabilities of CBD, it is prematurely to quit on penicillin.

Although it is believed that the efficiency of CBD might come from the method it assaults the biofilm surrounding bacterial cells, the authors are still not sure of the mechanism of action of CBD. They also did not think twice to explain the drawbacks of the study. Dr. Blaskovich pointed out that because the results are in the preliminary phases, it is far prematurely for individuals to start treating their CBD infections themselves. Check out CBD Topia for some great CBD products.

The study was also carried out in vitro (outside the human body), and there is a threat that the results of scientific trials will not be the same. Numerous substances have shown anti-bacterial efficacy in petri dishes, however then failed at this essential phase. It needs to also be pointed out that the two studies were carried out in cooperation with Botanix Pharmaceuticals Ltd, a pharmaceutical company concentrating on topical CBD products.

Nevertheless, this research could be an essential advance for CBD and the fight versus antimicrobial resistance. CBD continues to have a great security profile and is not considered hazardous even in big quantities. Thankfully, Dr. Blaskovich and his group strategy to continue their research.

Scroll to top